FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220983312> ?p ?o ?g. }

• W4220983312 endingPage "e27890" @default.
• W4220983312 startingPage "e27890" @default.
• W4220983312 abstract "Background Many prostate cancer (PC) survivors experience disease and treatment-related symptomatology in both the physical and psychosocial domains. Although the benefits and barriers to using web-based resources for cancer patients are well-documented, less research has focused on the personal characteristics important for efficient tailoring and targeting of information that are associated with usage. Objective We used the Cognitive-Social Health Information Processing (C-SHIP) framework to guide our exploration of personal characteristics associated with use of PROGRESS, an informational PC survivorship website that addresses physical, emotional, interpersonal, and practical concerns relevant for PC survivors. Methods PC survivors (N=217) were randomized to the intervention arm (PROGRESS) of a randomized controlled trial. Of those randomized to the intervention arm, 84 used PROGRESS, and 133 did not use PROGRESS. Multivariable analyses evaluated demographic and psychosocial characteristics (eg, style of coping, health literacy, self-efficacy, affective states of depression, anxiety, and fatigue) associated with website use. Results A larger proportion of non-Hispanic White (68/160, 42.5%), compared with non-Hispanic Black (9/40, 23%), participants used PROGRESS (P<.001). Further, PROGRESS users were older in age (P<.001), had a monitoring style of coping (P=.01), and were less depressed (P=.004), anxious (P=.02), and fatigued (P<.001) than nonusers. Education, income, health literacy, blunting style of coping, self-efficacy, and treatment type (radiation therapy or surgery) were not significantly related to use. On multivariable analyses, race (OR 0.28, P<.001), age (OR 1.05, P<.001), monitoring style of coping (OR 1.27, P=.02), and overall mood (OR 0.98, P<.001) remained significant. Conclusions A combination of monitoring and low levels of negative affect were associated with website use. Additionally, users were older, non-Hispanic White survivors. To ensure that important survivorship-relevant information reaches users, future efforts need to focus on enhancing patient engagement. Trial Registration ClinicalTrials.gov NCT02224482; https://clinicaltrials.gov/ct2/show/NCT02224482" @default.
• W4220983312 created "2022-04-03" @default.
• W4220983312 creator A5013305808 @default.
• W4220983312 creator A5025874222 @default.
• W4220983312 creator A5054358507 @default.
• W4220983312 creator A5067485237 @default.
• W4220983312 creator A5071890517 @default.
• W4220983312 creator A5076231258 @default.
• W4220983312 creator A5076417303 @default.
• W4220983312 date "2022-03-21" @default.
• W4220983312 modified "2023-09-26" @default.
• W4220983312 title "Demographic and Psychosocial Characteristics Associated With Use of a Prostate Cancer Survivorship Website: Implications From a Multisite Randomized Controlled Trial" @default.
• W4220983312 cites W104460701 @default.
• W4220983312 cites W1499259786 @default.
• W4220983312 cites W1740994973 @default.
• W4220983312 cites W1964998916 @default.
• W4220983312 cites W1967470185 @default.
• W4220983312 cites W1981263440 @default.
• W4220983312 cites W1982743587 @default.
• W4220983312 cites W1988346107 @default.
• W4220983312 cites W1999061866 @default.
• W4220983312 cites W2000445173 @default.
• W4220983312 cites W2016075247 @default.
• W4220983312 cites W2018676321 @default.
• W4220983312 cites W2022051113 @default.
• W4220983312 cites W2034544857 @default.
• W4220983312 cites W2035228137 @default.
• W4220983312 cites W2035721753 @default.
• W4220983312 cites W2040468793 @default.
• W4220983312 cites W2043191079 @default.
• W4220983312 cites W2064589361 @default.
• W4220983312 cites W2066771695 @default.
• W4220983312 cites W2079037116 @default.
• W4220983312 cites W2094965015 @default.
• W4220983312 cites W2106902595 @default.
• W4220983312 cites W2112778345 @default.
• W4220983312 cites W2126800506 @default.
• W4220983312 cites W2142005254 @default.
• W4220983312 cites W2142352888 @default.
• W4220983312 cites W2151253947 @default.
• W4220983312 cites W2174606085 @default.
• W4220983312 cites W2276782240 @default.
• W4220983312 cites W2583859787 @default.
• W4220983312 cites W2734216341 @default.
• W4220983312 cites W2747463790 @default.
• W4220983312 cites W2761161269 @default.
• W4220983312 cites W2784049123 @default.
• W4220983312 cites W2789266328 @default.
• W4220983312 cites W2793451000 @default.
• W4220983312 cites W2795762275 @default.
• W4220983312 cites W2799698792 @default.
• W4220983312 cites W2800389076 @default.
• W4220983312 cites W2801428940 @default.
• W4220983312 cites W2810468607 @default.
• W4220983312 cites W2921889822 @default.
• W4220983312 cites W2943630935 @default.
• W4220983312 cites W2947307188 @default.
• W4220983312 cites W2955002383 @default.
• W4220983312 cites W2956791603 @default.
• W4220983312 cites W3043456724 @default.
• W4220983312 cites W3156532412 @default.
• W4220983312 doi "https://doi.org/10.2196/27890" @default.
• W4220983312 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35311678" @default.
• W4220983312 hasPublicationYear "2022" @default.
• W4220983312 type Work @default.
• W4220983312 citedByCount "2" @default.
• W4220983312 countsByYear W42209833122023 @default.
• W4220983312 crossrefType "journal-article" @default.
• W4220983312 hasAuthorship W4220983312A5013305808 @default.
• W4220983312 hasAuthorship W4220983312A5025874222 @default.
• W4220983312 hasAuthorship W4220983312A5054358507 @default.
• W4220983312 hasAuthorship W4220983312A5067485237 @default.
• W4220983312 hasAuthorship W4220983312A5071890517 @default.
• W4220983312 hasAuthorship W4220983312A5076231258 @default.
• W4220983312 hasAuthorship W4220983312A5076417303 @default.
• W4220983312 hasBestOaLocation W42209833121 @default.
• W4220983312 hasConcept C118552586 @default.
• W4220983312 hasConcept C121608353 @default.
• W4220983312 hasConcept C126322002 @default.
• W4220983312 hasConcept C150966472 @default.
• W4220983312 hasConcept C15744967 @default.
• W4220983312 hasConcept C160735492 @default.
• W4220983312 hasConcept C162324750 @default.
• W4220983312 hasConcept C168563851 @default.
• W4220983312 hasConcept C172400760 @default.
• W4220983312 hasConcept C2777858393 @default.
• W4220983312 hasConcept C2778087770 @default.
• W4220983312 hasConcept C2778843546 @default.
• W4220983312 hasConcept C50522688 @default.
• W4220983312 hasConcept C542102704 @default.
• W4220983312 hasConcept C558461103 @default.
• W4220983312 hasConcept C70410870 @default.
• W4220983312 hasConcept C71924100 @default.
• W4220983312 hasConcept C73282008 @default.
• W4220983312 hasConcept C74909509 @default.
• W4220983312 hasConceptScore W4220983312C118552586 @default.
• W4220983312 hasConceptScore W4220983312C121608353 @default.
• W4220983312 hasConceptScore W4220983312C126322002 @default.

• next